Provided by Tiger Fintech (Singapore) Pte. Ltd.

InspireMD

2.55
+0.03001.19%
Post-market: 2.550.00000.00%19:15 EDT
Volume:10.24K
Turnover:26.33K
Market Cap:78.12M
PE:-3.34
High:2.69
Open:2.50
Low:2.50
Close:2.52
Loading ...

Company Profile

Company Name:
InspireMD
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
86
Office Location:
6303 Waterford District Drive,Suite 215,Miami,Florida,United States
Zip Code:
33126
Fax:
- -
Introduction:
InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Directors

Name
Position
Marvin Slosman
President, Chief Executive Officer and Director
Paul Stuka
Chairman of the Board
Gary Roubin
Director
Kathryn Arnold
Director
Michael Berman
Director
Thomas J. Kester
Director

Shareholders

Name
Position
Marvin Slosman
President, Chief Executive Officer and Director
Andrea Tommasoli
Chief Operating Officer
Amir Kohen
Interim Chief Financial Officer, Secretary and Treasurer
Craig Shore
Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer
Shane Gleason
General Manager of North America and VP of Global Marketing